Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harry Bloomfield Insider Profile
4 Followers
Harry Bloomfield, Director at Britannia Life Sciences Inc, holds 756.67K shares in Britannia Life Sciences Inc (Ticker: TSE:BLAB), holds 431.33K shares in Algernon Pharmaceuticals (Ticker: AGNPF). Most recently, Harry Bloomfield ― shares of Britannia Life Sciences Inc on ― for an estimated value of ―.
Harry Bloomfield Britannia Life Sciences Inc (BLAB)Director
Britannia Life Sciences Inc (BLAB)
Director
Ranked #91,844 out of 98,909 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-67.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Harry Bloomfield holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 31, 2021 - Dec 31, 2022
Return:-50.60%
The most profitable trade made by Harry Bloomfield
Harry Bloomfield's Trading History
Britannia Life Sciences Inc
―
Director
―
C$60.53K
Algernon Pharmaceuticals
Feb 09, 2024
Director
Uninformative Sell
―
$38.82K
List of latest transactions for each holding click on a transaction to see Harry Bloomfield's performance on stock
You May Also Like
Harry Bloomfield insider profile FAQ
What is the percentage of profitable transactions made by Harry Bloomfield?
The percentage of profitable transactions made by Harry Bloomfield is 0%.
What is the average return per transaction made by Harry Bloomfield?
The average return per transaction made by Harry Bloomfield is -67.20%.
What stocks does Harry Bloomfield hold?
Harry Bloomfield holds: TSE:BLAB, AGNPF stocks.
What was Harry Bloomfield’s latest transaction?
Harry Bloomfield latest transaction was an Uninformative Buy of ―.
What was Harry Bloomfield's most profitable transaction?
Harry Bloomfield’s most profitable transaction was an Informative Buy of AGNPF stock on December 31, 2021. The return on the trade was -50.60%.
What is Harry Bloomfield's role in Britannia Life Sciences Inc?
Harry Bloomfield's role in Britannia Life Sciences Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.